Stay updated on MBG453 Combo in IPSS-R MDS Clinical Trial
Sign up to get notified when there's something new on the MBG453 Combo in IPSS-R MDS Clinical Trial page.

Latest updates to the MBG453 Combo in IPSS-R MDS Clinical Trial page
- CheckyesterdayChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference3%
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check23 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference6%
- Check51 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.3%
- Check66 days agoChange DetectedThe web page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.SummaryDifference0.9%
- Check73 days agoChange DetectedNovartis has decided to terminate the sabatolimab clinical development program early due to the failure of Phase II and III studies to meet their primary objectives, although this decision was not based on safety concerns.SummaryDifference6%
Stay in the know with updates to MBG453 Combo in IPSS-R MDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MBG453 Combo in IPSS-R MDS Clinical Trial page.